All posts tagged
Celyad gets FDA Fast Track to Tackle Heart Failure with Cell Therapy
Novartis Gains Access to Celyad’s allogenic CAR-T cell patents
Which EU Immuno-Oncology Company are you Cheering for?
What are the Best Countries to Recruit Biotech Talents in 2017?
CAR-T Competition Heats Up with a New IND Approval
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
10 Hot European Biotechs to Observe in 2017 🚀
The 8 Biggest Biotech Medical Fails of 2016 in Europe
How is European Immuno-Oncology fighting Blood Cancer?
Celyad’s Autologous CAR-T Therapy enters Phase Ib
Debunking the Immuno-Oncology Hype: is it as good as it sounds?
Labiotech UG, All Rights Reserved -
Send this to friend